Trials / Completed
CompletedNCT03040622
The Evaluation of Thrombogenicity in Patients Undergoing WATCHMAN Left Atrial Appendage Closure Trial
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Inova Health Care Services · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate thrombogenicity in patients undergoing left atrial appendage closure using the WATCHMAN device. Parameters of thrombosis and platelet function, as well as other bio-markers, will be measure before, during, and after WATCHMAN implantation at several follow up visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | WATCHMAN Left Atrial Appendage Closure | WATCHMAN Left Atrial Appendage Closure |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2019-10-15
- Completion
- 2019-12-31
- First posted
- 2017-02-02
- Last updated
- 2024-03-29
- Results posted
- 2024-03-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03040622. Inclusion in this directory is not an endorsement.